Chapter: Hepatitis B and C

1. Analyze hepatitis B virus (HBV) serology to identify patients who would benefit from vaccination and those who require additional evaluation and monitoring.
2. Distinguish patients who are candidates for treatment of chronic HBV, and make appropriate treatment recommendations.
3. Discover distinctions between hepatitis C virus (HCV) antiviral regimens, including dosing, drug interactions, and applications for special populations.
4. Design evidence-based HCV regimens on the basis of individual patient characteristics. 

Chapter: Inflammatory Bowel Disease

1. Distinguish between Crohn disease (CD) and ulcerative colitis (UC), including disease severity classifications.
2. Assess goals of therapy and efficacy for people receiving treatment for inflammatory bowel disease (IBD).
3. Evaluate the efficacy and safety data for medications used to treat IBD.
4. Develop evidence-based, person-centered treatment regimens for IBD that incorporate laboratory monitoring, immunization considerations, pharmacologic and nonpharmacologic treatment recommendations, counseling points, and consideration of drug-specific factors. 

Chapter: Irritable Bowel Syndrome

1. Distinguish between different types of irritable bowel syndrome (IBS).
2. Assess the efficacy and safety data for medications used to treat IBS with diarrhea (IBS-D) and IBS with constipation (IBS-C).
3. Devise a treatment plan for patients, considering drug-specific factors for medications used to treat IBS.
4. Develop evidence-based, patient-centered treatment regimens for IBS considering drugspecific factors. 

Chapter: Celiac Disease

1. Analyze the epidemiology and pathophysiology of celiac disease (CD) and the impact on a patient’s health and wellness.
2. Evaluate the clinical presentation (i.e., symptoms, laboratory findings, medical history, risk factors, and complications) of a patient with CD.
3. Assess the effectiveness and safety of current therapeutic strategies for CD, including both dietary and pharmacotherapeutic options.
4. Distinguish regulatory standards and guidelines for gluten products and how to safely select food, supplements, and pharmaceutical products.
5. Develop a plan to prevent and manage nutritional deficiencies in a patient with CD. 

Chapter: Medication Use After Bariatric Surgery

1. Discover appropriate and inappropriate medications used after bariatric surgery.
2. Design a plan for treating or preventing vitamin deficiencies in patients after bariatric surgery.
3. Design a plan for treating or preventing complications in patients during perioperative bariatric surgery.
4. Resolve drug therapy problems associated with medications after bariatric surgery.
5. Assess disease states that benefit from bariatric surgery. 

Chapter: Clostridioides difficile Infection

1. Assess patients for risk factors for Clostridioides difficile infection (CDI).
2. Design a patient-specific treatment plan for the management of CDI.
3. Develop educational material and counseling tips for patients receiving treatment for CDI.
4. Devise strategies to prevent the development and transmission of CDI. 

Chapter: Weight Management

1. Distinguish among nonpharmacologic approaches to weight management.
2. Assess the efficacy and safety data for medications used in weight management.
3. Design a treatment plan for a patient desiring to lose weight, including patients of special populations.
4. Assess the pharmacist’s role in weight management. 

Interactive Case: Proton Pump Inhibitor Deprescribing

1. Analyze risks associated with long-term proton pump inhibitor (PPI) use.
2. Distinguish patients who are candidates for PPI deprescribing from those who are not.
3. Assess evidence-based resources available for PPI deprescribing.
4. Develop a clinical care plan for deprescribing PPIs when given a patient case. 

Interactive Case: Nonprescription Gastrointestinal Disorder Treatment

1. Demonstrate a systematic approach to evaluate a patient seeking nonprescription medication for common GI concerns.
2. Evaluate the appropriateness of treating a patient’s symptoms with nonprescription medication, and distinguish patients who are not candidates for self-care and should be referred.
3. Develop a pharmacologic and nonpharmacologic plan for a patient with common GI concerns. 

Recorded Webcast: Nausea and Vomiting

1. Distinguish the differences between the different etiologies, risk factors, and causes of nausea and vomiting (N/V) syndromes, including general, chemotherapy induced, radiation induced, postoperative, and pregnancy induced.
2. Evaluate the available nonpharmacologic and pharmacologic therapies with respect to mechanism of action, clinical uses, and drug-specific factors.
3. Analyze the available literature and guidelines surrounding the treatment of various types of N/V.
4. Develop evidence-based treatment regimens for N/V considering the etiology, risk factors, and drug-specific factors.